Product Information
FERRIC CITRATE 210 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $6.2539 per EA under NDC 00378289520. Its NADAC has been published 53 times since Aug 20, 2025.
FDA first approved this application on Sep 5, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
210 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378289520
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TETRAFERRIC TRICITRATE DECAHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205874FDA Approved
9/5/2014
TE Code
AB
On Market Since
3/20/2025
Pharmacological Classes
Price Statistics
The NADAC for FERRIC CITRATE 210 MG TABLET has been published 53 times since Aug 20, 2025, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.2539 per EA |
|---|---|
| All-time high | $6.3712 (Aug 12, 2026) |
| All-time low | $5.7002 (Aug 20, 2025) |
| 52-week high | $6.3712 |
| 52-week low | $5.7002 |
| Median price | $6.2539 |
| Average price | $6.1671 |
| Largest weekly change | +3.4% (Sep 17, 2025) |
| Weeks tracked | 53 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ferric Citrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FERRIC CITRATE 210 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FERRIC CITRATE 210 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $6.2539 per EA (NDC 00378289520), effective Aug 19, 2026.
How has the price of FERRIC CITRATE 210 MG TABLET changed over time?
Over the history we have for it, the NADAC for FERRIC CITRATE 210 MG TABLET has risen 9.7%. It has been tracked across 53 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for FERRIC CITRATE 210 MG TABLET?
Since Aug 20, 2025, the NADAC for FERRIC CITRATE 210 MG TABLET has ranged from a low of $5.7002 (Aug 20, 2025) to a high of $6.3712 (Aug 12, 2026), with a median of $6.2539 per EA.
Are there cheaper alternatives to FERRIC CITRATE 210 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FERRIC CITRATE 210 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FERRIC CITRATE 210 MG TABLET?
FERRIC CITRATE 210 MG TABLET (NDC 00378289520) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.